High-frequency hemodialysis: Rationale for randomized clinical trials

Clinical Journal of the American Society of Nephrology

Volumn 2, Issue 2, 2007, Pages 390-392

  Kliger, Alan S ^a  

^a HOSPITAL OF SAINT RAPHAEL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC KIDNEY FAILURE; HUMAN; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY; REVIEW; STATISTICS;

HUMANS; KIDNEY FAILURE, CHRONIC; RANDOMIZED CONTROLLED TRIALS; RENAL DIALYSIS;

EID: 34250832310     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.03110906     Document Type: Article

References (22)

1. US Renal Data System. USRDS 2005 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Available at: http://www.usrds.org/adr_2005.htm
2. National Kidney Foundation Dialysis Outcome Quality Initiative: NKF-DOQI Clinical Practice Guidelines for Hemodialysis Adequacy, New York, National Kidney Foundation, 1997
3. Guidelines for treating patients with chronic renal failure. J Am Soc Nephrol 10[Suppl]: S287-S321, 1999
4. The CARI Guidelines. Caring for Australasians with Renal Impairment. Available at: http://www.cari.org.au
5. Wolfe RA, Ashby VB, Daugirdas JT, Agodoa LY, Jones CA, Port FK: Body size, dose of hemodialysis, and mortality. Am J Kidney Dis 35: 80-88, 2000
6. Port FK, Ashby VB, Dhingra RK, Roys EC, Wolfe RA: Dialysis dose and body mass index are strongly associated with survival in hemodialysis patients. J Am Soc Nephrol 13: 1061-1066, 2002
7. Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, Allon M, Bailey J, Delmez JA, Depner TA, Dwyer JT, Levey AS, Levin NW, Milford E, Ornt DB, Rocco MV, Schulman G, Schwab SJ, Teehan BP, Toto R; for the hemodialysis (HEMO) study group: Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347: 2010-2019, 2002
8. Block GA, Hulbert-Shearon TE, Levin NW, Port FK: Association of serum phosphorus and calcium × phosphate product with mortality risk in chronic hemodialysis patients: A national study. Am J Kidney Dis 31: 607- 617, 1998
9. Marshall MR, Byrne BG, Kerr PG, McDonald SP: Associations of hemodialysis dose and session length with mortality risk in Australian and New Zealand patients. Kidney Int 69: 1229-1236, 2006
10. Saran R, Bragg-Gresham JL, Levin NW, Twardowski ZJ, Wizemann V, Saito A, Kimata N, Gillespie BW, Combe C, Bommer J, Akiba T, Mapes DL, Young EW, Port FK: Longer treatment time and slower ultrafiltration in hemodialysis: Associations with reduced mortality in the DOPPS. Kidney Int 69: 1222-1228, 2006
11. Chertow GM, Kurella M, Lowrie EG: The tortoise and hare on hemodialysis: Does slow and steady win the race? Kidney Int 70: 24-25, 2006
12. Cheung AK, Levin NW, Greene T, Agodoa L, Bailey J, Beck G, Clark W, Levey AS, Leypoldt JK, Ornt DB, Rocco MV, Schulman G, Schwab S, Teehan B, Eknoyan G; for the HEMO study group: Effects of high-flux hemodialysis on clinical outcomes: Results of the HEMO study. J Am Soc Nephrol 14: 3251-3263, 2003
13. Depner T, Daugirdas J, Greene T, Allon M, Beck G, Chumlea C, Delmez J, Gotch F, Kusek J, Levin N, Macon E, Milford E, Owen W, Star R, Toto R, Eknoyan G; for the Hemodialysis (HEMO) Study Group: Dialysis dose and the effect of gender and body size on outcome in the HEMO study. Kidney Int 65: 1386-1394, 2004
14. Greene T: What did we learn from the HEMO study? Implications of secondary analyses. Contrib Nephrol 149: 69-82, 2005
15. Depalma JR, Pecker EA, Maxwell MH: A new automatic coil dialyser system for 'daily' dialysis. Proc Eur Dial Transplant Assoc 6: 26-34, 1969
16. Walsh M, Culleton B, Tonelli M, Manns B: A systematic review of the effect of nocturnal hemodialysis on blood pressure, left ventricular hypertrophy, anemia, mineral metabolism, and health-related quality of life. Kidney Int 67: 1500-1508, 2005
17. Suri RS, Nesrallah GE, Mainra R, Garg AX, Lindsay RM: Daily hemodialysis: A systemic review. Clin J Am Soc Nephrol 1: 33-42, 2006
18. Fagugh RM, Reboldi G, Quintaliani G, Pasini P, Ciao G, Cicconi B, Pasticci F, Kaufman JM, Buoncristiani U: Short daily hemodialysis: Blood pressure control and left ventricular mass reduction in hypertensive hemodialysis patients. Am J Kidney Dis 38: 371-376, 2001
19. Chertow GM: "Wishing don't make it so": Why we need a randomized clinical trial of high-intensity hemodialysis. J Am Soc Nephrol 12: 2850-2853, 2001
20. Writing Group for the Women's Health Initiative Investigators: Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the women's health initiative randomized controlled trial. JAMA 288: 321-333, 2002
21. Laine C: Postmenopausal hormone replacement therapy: How could we have been so wrong? Ann Intern Med 137: 290, 2002
22. Suri RS, Garg AX, Chertow GM, Levin NW, Rocco MV, Greene T, Beck GJ, Gassman JJ, Eggers PW, Starr RA, Ornt DB, Kliger AS; Frequent Hemodialysis Network (FHN) Trial Group: Frequent Hemodialysis Network (FHN) randomized trials: Study design. Kidney Int 71: 349-359, 2007